Evidence map›Paper›PMID 33806932›Full record

ArticleBiomedicines2021

Long-Term Treatment of Azathioprine in Rats Induces Vessel Mineralization.

Mirjam Schuchardt, Jaqueline Herrmann, Cornelia Henkel, Milen Babic, Markus van der Giet, Markus Tölle

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mirjam SchuchardtDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.ORCID 0000-0001-7388-9611
Jaqueline HerrmannDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
Cornelia HenkelDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
Milen BabicDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
Markus van der GietDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.
Markus TölleDepartment of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, 12203 Berlin, Germany.ORCID 0000-0001-9843-2132
Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DE

Funding

Ernst-und-Berta-Grimmke Stiftung none.Sonnenfeld Stiftung none
6 · The paper itself

Abstract

Medial vascular calcification (mVC) is closely related to cardiovascular disease, especially in patients suffering from chronic kidney disease (CKD). Even after successful kidney transplantation, cardiovascular mortality remains increased. There is evidence that immunosuppressive drugs might influence pathophysiological mechanisms in the vessel wall. Previously, we have shown in vitro that mVC is induced in vascular smooth muscle cells (VSMCs) upon treatment with azathioprine (AZA). This effect was confirmed in the current study in an in vivo rat model treated with AZA for 24 weeks. The calcium content increased in the aortic tissue upon AZA treatment. The pathophysiologic mechanisms involve AZA catabolism to 6-thiouracil via xanthine oxidase (XO) with subsequent induction of oxidative stress. Proinflammatory cytokines, such as interleukin (IL)-1ß and IL-6, increase upon AZA treatment, both systemically and in the aortic tissue. Further, VSMCs show an increased expression of core-binding factor α-1, alkaline phosphatase and osteopontin. As the AZA effect could be decreased in NLRP3

Indexed as

agingazathioprinecalcificationmineralizationsenescence-associated secretory phenotype

Identifiers

PMID33806932
PMCPMC8004774
OpenAlexW3135953469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.